“…According to the carbon-atom number of monomers, PHA can be divided into two categories, namely short-chain length (SCL) PHA generally containing 3-5 carbon atoms (C3-C5), such as 3-hydroxybutyrate (3HB), 4-hydroxybutyrate (4HB), 3-hydroxyvalerate (3HV), 3-hydroxypropoinate (3HP), etc., and medium/long-chain length (M/LCL) PHA with over 5 carbon atoms (≥C6) ( Choi et al, 2020b ; Meng et al, 2014 ; Zhang et al, 2018b ). Specifically, MCL PHA (C6-C14) and LCL PHA (≥C15) are generally accumulated by wild-type or recombinant Pseudomonas using fatty acids as carbon source ( Meng et al, 2014 ; Nikel and de Lorenzo, 2018 ; Prieto et al, 2016 ); ( Chen and Hajnal, 2015 ; Choi et al, 2020a ; Li et al, 2021b ; Singh and Mallick, 2009 ), while Ralstonia eutropha, Halomonas bluephagenesis TD01 and Escherichia coli have been developed to be promising workhorses for SCL PHA production with decades of research fundation and several industrial-scale successes. Herein, The major biosynthetic pathways of both SCL- and M/LCL-PHA by recombinant microbes from different structurally related and/or unrelated carbon sources (glucose, glycerol, fatty acids, etc.)…”